skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

The European Society of Cardiology’s 2014 Annual Congress was described as having the ‘strongest scientific program yet’ by Professor Keith Fox, the program chair. With a focus on innovation and the heart; 27 clinical Hot Line studies, 15 clinical trial updates, four new guidelines, and 4,597 abstracts were presented at the world’s leading cardiovascular disease conference.


Highlights include:

PARADIGM-HF: strength of LCZ696’s outcomes data suggests a new paradigm in the treatment of heart failure. With such promising morbidity and mortality data relative to the gold-standard therapy, LCZ696 has the potential to achieve blockbuster status in heart failure.



SOLID-TIMI: darapladib fails to meet primary endpoint in SOLID-TIMI 52 ACS trial after previous failure in chronic CHD. Unfortunately, targeting Lp-PLA2 has not translated into clinically meaningful results, and it is likely that darapladib’s development for cardiovascular disease will be discontinued.



ODYSSEY trials: alirocumab data demonstrate strong impact on lipid lowering and suggest CV outcomes benefit as the PCSK9 inhibitor class’s first-to-market race heats up.

Download your free whitepaper summary

Understand our expert view on the likely impact and implications with this free White Paper summary.




Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: